V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003766 | 280002793 | null | null | Neo-adjuvant (N) | 2015-01-05 | 2015-01-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280026114 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003767 | 280007365 | null | 109.4 | Curative (C) | 2014-08-04 | 2015-08-27 | Doxorubicin + Ifosfamide | N | N | 280026115 | DOXORUBICIN + IFOSFAMIDE |
| 280003768 | 280002794 | 1.85 | 72 | Curative (C) | 2014-08-27 | 2014-08-27 | CISPLATIN + FLUOROURACIL | 02 | N | 280026118 | CISPLATIN + FLUOROURACIL |
| 280003769 | 280002794 | 1.76 | null | null | 2018-01-17 | 2018-01-17 | CETUXIMAB + RT | 02 | N | 280026118 | CETUXIMAB + RT |
| 280003770 | 280002795 | 1.7 | 75.1 | null | 2014-11-24 | 2014-12-01 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | 280026121 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003771 | 280002795 | 1.63 | 82.2 | Palliative (P) | 2014-09-23 | 2014-09-23 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280026121 | CISPLATIN + FLUOROURACIL |
| 280003772 | 280002796 | 168 | 72 | Palliative (P) | 2017-07-25 | 2017-07-28 | Doxorubicin + Ifosfamide | N | N | 280026124 | DOXORUBICIN + IFOSFAMIDE |
| 280003773 | 280002797 | 1.69 | 71.4 | Palliative (P) | 2017-12-09 | 2017-12-22 | DOXORUBICIN + IFOSFAMIDE | 02 | N | 280026126 | DOXORUBICIN + IFOSFAMIDE |
| 280003774 | 280007368 | 1.64 | 80.2 | Adjuvant (A) | 2014-01-13 | 2014-01-28 | CETUXIMAB + RT | N | Y | 280026128 | CETUXIMAB + RT |
| 280003775 | 280002798 | 1.59 | 128 | Curative (C) | 2014-06-09 | 2014-06-14 | CISPLATIN + FLUOROURACIL | 2 | N | 280026129 | CISPLATIN + FLUOROURACIL |
| 280003776 | 280002799 | 1.82 | 78 | Curative (C) | 2017-02-23 | 2017-03-19 | CETUXIMAB + RT | 02 | N | 280026130 | CETUXIMAB + RT |
| 280003777 | 280002800 | 1.74 | 117.4 | Adjuvant (A) | 2013-04-28 | 2013-04-29 | Cisplatin +Fluorouracil (3 wk) | null | null | 280026131 | CISPLATIN + FLUOROURACIL |
| 280003778 | 280002801 | null | 57 | Disease modification (D) | 2016-01-06 | 2016-01-07 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280026135 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003779 | 280002802 | 1.83 | 80.6 | Palliative (P) | 2016-02-21 | 2016-02-29 | Cisplatin +Fluorouracil (3 wk) | N | N | 280026137 | CISPLATIN + FLUOROURACIL |
| 280003780 | 280002803 | 1.65 | 66.6 | Neo-adjuvant (N) | 2016-12-01 | 2016-12-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280026139 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003781 | 280002804 | 1.55 | 86.4 | Curative (C) | 2015-11-29 | 2015-11-29 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280026140 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003783 | 280002806 | null | null | Disease modification (D) | 2016-06-18 | 2016-07-06 | Doxorubicin + Ifosfamide | null | N | 280026142 | DOXORUBICIN + IFOSFAMIDE |
| 280003784 | 280002806 | 1.7 | 56 | Palliative (P) | 2014-12-08 | 2014-12-12 | DOXORUBICIN + IFOSFAMIDE | N | N | 280026142 | DOXORUBICIN + IFOSFAMIDE |
| 280003785 | 280002806 | 1.6 | 96.7 | Neo-adjuvant (N) | 2013-10-09 | 2013-10-21 | CISPLATIN + FLUOROURACIL | 02 | null | 280026142 | CISPLATIN + FLUOROURACIL |
| 280003786 | 280002806 | 1.7 | 96.3 | Curative (C) | 2014-03-26 | 2014-03-26 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280026142 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003787 | 280002807 | 1.76 | 64.4 | Neo-adjuvant (N) | 2015-08-08 | 2015-08-28 | Cetuximab + Radiotherapy Load | N | N | 280026147 | CETUXIMAB + RT |
| 280003788 | 280002808 | 1.8 | 89.9 | Palliative (P) | 2017-12-08 | 2018-01-06 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 280026148 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003789 | 280002809 | 1.67 | null | Neo-adjuvant (N) | 2013-10-31 | 2013-11-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 280026149 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003790 | 280002810 | 1.55 | 89.8 | null | 2013-08-18 | 2013-08-18 | Doxorubicin + Ifosfamide | N | N | 280026152 | DOXORUBICIN + IFOSFAMIDE |
| 280003791 | 280002810 | 1.67 | 67.05 | Curative (C) | 2015-06-28 | 2015-08-10 | Cetuximab + Radiotherapy Maint | 02 | Y | 280026152 | CETUXIMAB + RT |
| 280003792 | 280009760 | 1.54 | null | null | 2013-01-30 | 2013-02-01 | Cisplatin +Fluorouracil (3 wk) | N | N | 280026160 | CISPLATIN + FLUOROURACIL |
| 280003793 | 280002811 | 1.52 | 79.4 | Palliative (P) | 2017-01-01 | 2017-01-11 | Cisplatin +Fluorouracil (3 wk) | N | N | 280026161 | CISPLATIN + FLUOROURACIL |
| 280003794 | 280002812 | 1.68 | 93 | Adjuvant (A) | null | 2016-12-28 | Doxorubicin + Ifosfamide | N | N | 280026163 | DOXORUBICIN + IFOSFAMIDE |
| 280003795 | 280002813 | 1.73 | 97.5 | Curative (C) | 2016-11-18 | 2016-11-20 | Cetuximab + Radiotherapy Load | 02 | Y | 280026165 | CETUXIMAB + RT |
| 280003796 | 280002813 | 1.71 | 71.2 | Neo-adjuvant (N) | 2015-09-29 | 2015-10-02 | CISPLATIN + FLUOROURACIL | 02 | null | 280026165 | CISPLATIN + FLUOROURACIL |
| 280003797 | 280002813 | 1.85 | 71 | Curative (C) | 2016-03-28 | 2016-04-11 | CETUXIMAB + RT | 02 | Y | 280026165 | CETUXIMAB + RT |
| 280003798 | 280002814 | 1.5 | 76.2 | Curative (C) | 2017-04-07 | 2017-04-10 | CISPLATIN + FLUOROURACIL | 2 | N | 280026170 | CISPLATIN + FLUOROURACIL |
| 280003799 | 280007372 | null | null | null | 2014-07-10 | 2014-09-18 | Cisplatin +Fluorouracil (3 wk) | N | N | 280026172 | CISPLATIN + FLUOROURACIL |
| 280003800 | 280002815 | 1.87 | 75.8 | Not known (9) | 2013-03-28 | 2013-05-01 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280026175 | CISPLATIN + FLUOROURACIL |
| 280003801 | 280002816 | null | 83 | Curative (C) | 2015-05-16 | 2015-06-06 | Cetuximab + Radiotherapy Load | N | Y | 280026177 | CETUXIMAB + RT |
| 280003802 | 280002817 | 1.76 | null | Neo-adjuvant (N) | 2014-02-12 | 2014-03-24 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280026178 | CISPLATIN + FLUOROURACIL |
| 280003803 | 280002818 | 1.62 | 93.8 | Neo-adjuvant (N) | 2013-11-13 | 2013-11-28 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280026179 | CISPLATIN + FLUOROURACIL |
| 280003804 | 280007373 | 1.7 | 77 | null | 2014-02-01 | 2014-02-18 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280026182 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003805 | 280002819 | 1.69 | 91.9 | Curative (C) | 2016-01-17 | 2016-02-14 | Cetuximab + Radiotherapy Load | 02 | Y | 280026183 | CETUXIMAB + RT |
| 280003806 | 280002819 | 1.5 | 90.6 | Neo-adjuvant (N) | 2013-10-07 | 2013-10-09 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | null | 280026183 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003807 | 280002819 | 1.51 | 92 | Neo-adjuvant (N) | null | 2015-03-14 | CISPLATIN + FLUOROURACIL | N | N | 280026183 | CISPLATIN + FLUOROURACIL |
| 280003808 | 280002820 | 1.61 | null | Curative (C) | 2014-10-04 | 2014-10-04 | Cetuximab + Radiotherapy Load | 2 | Y | 280026188 | CETUXIMAB + RT |
| 280003809 | 280002820 | 1.82 | 77 | Neo-adjuvant (N) | 2016-11-14 | 2016-11-20 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280026188 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003810 | 280009763 | 1.69 | 48 | Curative (C) | null | 2018-01-31 | CETUXIMAB + RT | N | Y | 280026192 | CETUXIMAB + RT |
| 280003811 | 280002821 | 1.77 | 93 | null | 2016-07-18 | 2016-07-28 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280026194 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003812 | 280007376 | 1.52 | 44.5 | null | 2017-04-17 | 2017-04-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280026195 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003813 | 280007376 | 1.6 | 80 | null | 2017-03-25 | 2017-04-07 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280026195 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003814 | 280002822 | 1.73 | 71 | Curative (C) | 2017-11-24 | 2017-11-28 | CETUXIMAB + RT | N | N | 280026198 | CETUXIMAB + RT |
| 280003815 | 280002822 | 1.54 | null | Curative (C) | 2017-10-28 | 2017-10-28 | CETUXIMAB + RT | null | null | 280026198 | CETUXIMAB + RT |
| 280003816 | 280009765 | 1.65 | 67.5 | Neo-adjuvant (N) | 2018-04-29 | 2018-05-02 | Doxorubicin + Ifosfamide | 2 | N | 280026202 | DOXORUBICIN + IFOSFAMIDE |